samedan logo
 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Dempsey Demystifies Regulatory Cycle at DIA Europe

RWS Life Sciences

Sheena Dempsey Speaks at DIA Europe 2018


 
March 22, 2018 (Hartford, Conn.) – RWS Life Sciences Managing Director, Sheena Dempsey, will present “Demystifying the Multilingual Complexities in the Regulatory Cycle” at DIA Europe 2018, on April 17, at 3:30PM (CET), in Basel, Switzerland.

Ms. Dempsey, who leads the world’s second largest life science translation practice, offers a unique perspective to the audience. As a language services provider experienced in working with regulatory teams in the medical device and pharmaceutical industries, she will discuss the hidden challenges of managing regulatory concerns in an increasingly multilingual and global market.

“My presentation will focus on the benefits of understanding the nuances of the linguistic requirements of each regional authority,” states Dempsey. “There are a host of challenges that face pharma and med device companies seeking regulatory approvals, and the language component is not necessarily in their comfort zone.”

RWS Life Sciences will also exhibit at DIA Europe at Booth 4. The three-day program for DIA Europe 2018 addresses the entire health care value chain ranging from policy and regulations to R&D, marketing, and access. More information is available at http://www.diaglobal.org/en.

About RWS Life Sciences

Under the umbrella of RWS, the world’s leading provider of global language solutions, RWS Life Sciences is the world’s second largest life sciences translation practice and provides a full suite of language services exclusively for the life sciences industry. Visit us online at www.rws.com/lifesciences.
phone +1 860 727 6000
email http://www.rws.com/lifesciences
web www.rws.com
email 101 East River Drive, East Hartford, CT 06108
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Nemera organized an expert review on the present and future of inhalation products

“Connectivity in every new inhalation device?” This topic was one of those discussed with different inhalation experts - Manfred Keller, Pascal Cavaillon and Henry Chrystyn – during a round table organized by Nemera in Paris to review the advantages and limitations of inhalation devices.
More info >>


White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

Industry Events

Biotech Showcase™ 2019

7-9 January 2019, Hilton San Francisco Union Square

Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement